leisure time -WSS

leisure time

author：focus 2025-09-27 09:59:06 - browse：64859

AI skin cancer detector, dermasensor. -- health tech coverage from STAT — Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but it’s also not that deadly when caught early. Courtesy DermaSensor

The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots.

Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early.

The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level. It will be marketed specifically for primary care physicians to use in routine check-ups in patients aged 40 and above.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： 23andMe had bad news about my health. I wish a person had delivered it

WSS

How to make the FDA’s new prescription one

Wildfire smoke exposes gaps in outdoor worker protections

How medical schools plan to diversify without affirmative action

FDA proposes changes to key medical devices approval pathway

Walmart eyes Medicare Advantage provider ChenMed

What does generative AI mean for health care? We asked experts

knowledge

leisure time

hotspot

Sports medicine is finally prioritizing gender equality

Alkermes shareholders re

Walensky prepares to leave CDC — and Congress — behind

Continuity nursing helped my family in our darkest PICU moments

ChatGPT in medicine: STAT answers readers' burning questions

FDA panel endorses Alnylam’s heart drug — after picking it apart

How one medical school became remarkably diverse

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

The high cost of giving birth even with insurance

Generate Biomedicines machine learning biotech raises $273M

focus

The cancer drug shortage isn’t new — and neither are the solutions

How to make the FDA’s new prescription one

Bright Health sells Medicare Advantage business to Molina

Trump demands the U.S. pay no more for drugs than other countries … again

Hollywood unions extend contract negotiations for actors

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

hotspot

hotspot

Wikipedia

entertainment